Deutsche Bank analyst Brian Bedell lowered the firm’s price target on CME Group to $193 from $195 and keeps a Hold rating on the shares. The company reported mixed Q2 results and uncertainties around volume growth remain, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group Inc. Reports All-Time Record Revenue of $1.5 Billion for Q2 2024
- CME Group reports Q2 adjusted EPS $2.56, consensus $2.53
- CME Upcoming Earnings Report: What to Expect?
- CME Group price target lowered to $208 from $228 at Barclays
- CME Group price target lowered to $235 from $250 at Piper Sandler